Obagi Medical Products, Inc. (OMPI) Tops Q2 EPS by 4c
Tweet Send to a FriendGet Alerts OMPI Hot Sheet
Price: $23.98 --0%
EPS Growth %: -37.5%
Financial Fact:
Research and development expenses: 493K
Today's EPS Names:
LBIX, ESEA, ISS, More
EPS Growth %: -37.5%
Financial Fact:
Research and development expenses: 493K
Today's EPS Names:
LBIX, ESEA, ISS, More
Trade OMPI Now!
Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q2 EPS of $0.18, $0.04 better than the analyst estimate of $0.14. Revenue for the quarter came in at $30.5 million versus the consensus estimate of $30.39 million.
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Applied Materials, Inc. (AMAT) Tops Q2 EPS by 3c, Offers Guidance
- Sina Corp (SINA) Tops Q1 EPS by 5c, Offers Guidance
- Stage Stores, Inc. (SSI) Posts Surprise Q1 Loss of 2c/Share
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
